Flexotron Cross 60mg/3ml, syringe

The medical device is indicated for the treatment of joint pain in osteoarthritis (OA).

Active ingredient

Sodium hyaluronate

Composition

Sterile viscoelastic implant for intra-articular injection Flexotron ^® Cross, based on cross-linked sodium hyaluronate, 60 mg/3.0 ml, in glass syringes.

How to take, the dosage

The implant is injected in the volume contained in one syringe for one adult patient into the joint affected by osteoarthritis (OA).

Course: intra-articular 1 syringe. The dosage is 3 ml per course of treatment, so adults should inject the entire contents of the syringe. The effectiveness of the product lasts at least 6 months.

.

Synopsis

Flexotron^® Cross is the first bionic cross-linked hyaluronic acid preparation for single injection on the Russian market. It is cross-linked using the patented CHAP technology. Stays in the joint 20 times longer than linear hyaluronic acid. Has a perfect combination of elastic and viscous properties. Easy to inject and easily tolerated by patients.

Contraindications

Do not use the implant to treat patients who are hypersensitive to hyaluronate-based products.

Intra-articular injections are contraindicated if there are past or current infections or skin conditions in the vicinity of the injection site.

Side effects

The main side effects of the implant are pain, swelling, and stiffness in the joint where the injection was made.

Similarities

Vizmed, Vizmed Light, Hilomax-Comod, Hilo-Comod, Uro-Gial, Vizmed multi, Stillavit, Avisor Moister Drops, Systain Ultra Plus, Ocutyarz, Gilan Ultra Comfort, Gilan Comfort, Plexatron